Our History
Background and Development.
The Mbale Clinical Research Institute (MCRI) was established as a research unit within Mbale Regional Referral Hospital, and it progressively developed by undertaking several clinical and biomedical research projects. Over the years, MCRI’s portfolio has gradually expanded to include different studies involving severe Anemia, severe pneumonia, Hydroxyurea with SCA, severe hypoxia, and Malaria, alongside many other major studies.
MCRI was founded in 2008 in response to the need for evidence-based clinical guidelines. With various partners at different stages in its development, the MCRI has remained focused on clinical research as an ingredient to inform the development of clinical guidelines in East Africa and similar settings in the region and beyond.
In 2016, MCRI was incorporated as a Company Limited by Guarantee and not have share capital under Reg No.223615.
For the past 10 years, we have mainly invested in building the frameworks and platforms for quality research. The Mbale Clinical Research Institute (MCRI) has provided high-quality Clinical Research, networking, and support to the clinical research community in Uganda. For many Members, the Institute has been part of their life throughout their research careers, many have been with the Institute since its first incarnation as Mbale Clinical Research Unit (MCRU). In the next 10 years, however, we plan to implement research on specific themes with local champions leading in each thematic area.
Company Overview
Mbale Clinical Research Institute conducts a series of clinical trials focusing on in-patient hospital care and out-patient healthcare. Notably evidence-based research involving molecular laboratory work, infectious diseases, emergency pediatrics, and community engagement. The approach that we have used emphasizes high-quality research, local capacity building of human resources, infrastructure, and equipping of the key research stations.
This approach has led to collaborations with both national and international partners including Mbale Regional Referral Hospital, Busitema University, KEMRI Wellcome Trust, JCRC, MUJHU, etc. We are dedicated to delivering the highest research quality and services. Over the years, MCRI’s portfolio has gradually expanded to include different studies involving Severe Anaemia, Severe Pneumonia, Hydroxyurea with SCA, Severe Hypoxia, Malaria, and HIV alongside many other major studies.